Excellent Research Support
Zwei flinke Boxer jagen die quirlige Eva und ihren Mops durch Sylt
At Protheragen, we are dedicated to pushing the boundaries of the field by providing diagnostic and therapeutic drug development services for a range of rare blood diseases. Through extensive preclinical studies, we evaluate a diverse array of innovative therapies using in vitro and in vivo models to ensure both their effectiveness and safety. Our goal is to support our customers' research in rare blood diseases and work together to fight these challenging diseases.
With rich expertise and advanced technology platforms, we are committed to providing one-stop solutions for the treatment of anemia, myeloproliferative and lymphoid diseases. Our goal is to advance the boundaries of rare blood disease treatment and accelerate your journey from therapeutic research to commercialization.
Diagnostic Development
Therapeutic Development
Disease Model Development
Preclinical Research
Myeloproliferative Disorders
Bleeding Disorders
Lymphoproliferative Disorders
Anemia
At our company, we value collaborative partnerships that drive innovation and progress in the field of rare blood diseases.
Our mission is to provide diagnostic and therapeutic development services to research institutions and pharmaceutical companies, among others, to expedite their research processes.
We are steadfastly dedicated to quality and innovation, striving to deliver unparalleled diagnostic and therapeutic drug development services to meet our customers' ever-evolving needs.
Myeloproliferative Disorders (MPDs)
Bone Marrow Failure Syndromes (BMFS)